Pancreatic Cancer UK funds world-leading research at the cutting-edge of science. We fund research through a number of approaches.
Only 2.1% of UK cancer research spend is directed towards pancreatic cancer annually. Pancreatic cancer needs bold investment to transform the future and to deliver the step change that can alter the outcome for those diagnosed with this devastating disease.
We are taking this challenge on. We are targeting this underfunding through funding schemes that support pioneering and innovative research. We are incredibly excited about the potential of our research programme now and in the future.